- About Us
- For Researchers
- For Students
- For Practitioners
- For Community
- Support Us
- Contact Us
People with an ID experience reduced life expectancy and an excessive morbidity burden compared to other Australians. Poor cardiometabolic health is one key area of inequality, including high rates of obesity, diabetes and hypertension. Factors that may make some people with ID more vulnerable to cardiometabolic ill-heath than the general population include: excessive psychotropic prescription and psychotropic polypharmacy; lower physical activity levels; unequal access to quality healthcare; pre-disposing genetic syndromes; and social exclusion and economic disadvantage. Positive and preventative interventions are needed to address excessive cardiometabolic morbidity and mortality in this population.
In collaboration with the authors of a previously published generalist cardiometabolic monitoring algorithm, “Positive cardiometabolic health: an early intervention framework for patients on psychotropic medication” (Curtis, Newall et al. 2011) we will develop a guideline to meet the specific needs and risk profiles of people with intellectual disability.
This project is phase one of a larger study investigating responsible psychotropic prescription in people with intellectual disability.
Please click here to access the framework.